Skip to content
-
EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access
Aug 27, 2025
EVERSANA has added Waltz Health to their organization. The combined company offers a next-generation commercialization model that... read more
-
Corporate Member Spotlight: Biologics by McKesson
Aug 26, 2025
NASP is pleased to shine the Spotlight on Biologics by McKesson, a corporate member of the month.... read more
-
Read the Latest Issue of The Advocate – 2025; Vol. 3
Aug 22, 2025
This issue of The Advocate highlights notable news and happenings across the industry and our organization. The Advocate is... read more
-
New Issue of Specialty Rx Advisor, from Cold Chain Technologies
Aug 13, 2025
The next issue of the Specialty Rx Advisor is available! This quarterly newsletter is a resource... read more
-
Health Care Innovation Publications from URAC
Aug 13, 2025
Is your summer reading list missing something about health care innovation? If so, check out these... read more
-
On Demand Webinar – Look Ahead: Hot Button Issues Facing Specialty Pharmacies in the Next 12 Months
Jul 29, 2025
Thank you to everyone who joined us for the webinar, “Look Ahead: Hot Button Issues Facing... read more
-
NASP Lunch & Learn Webinar – Leading the Future of Pharmacy-Driven Engagement for Complex Patient Journeys
Jul 24, 2025
The National Association of Specialty Pharmacy is pleased to announce a webinar presented by MedAdvisor Solutions... read more
-
New NASP Podcast – Rewriting the Rules: What’s Ahead for Non-PBM Affiliated Specialty Pharmacies
Jul 23, 2025
Click here to Listen! In this episode of the NASP Podcast, Sheila Arquette, President & CEO... read more
-
NASP Roundtable Webinar – Breaking the mold: What’s next for biosimilars and how to stay ahead
Jul 18, 2025
The National Association of Specialty Pharmacy is pleased to announce a webinar presented by Cencora, titled... read more
-
FDA Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer
Jul 02, 2025
Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in... read more